Keywords: Almirall, Nycomed, Roflumilast, Libertek, Spain, Financial guidance

Almirall launches Nycomed’s COPD drug roflumilast in Spain; revises guidance

Article | 04 October 2011

Print This

Spain’s largest pharma company Almirall (ALM. MC) has just launched in Spain the second brand of roflumilast under ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in